VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)
$0.251 0.0026 (1.0467%)
Analysed VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) News Sources
Vistagen Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
15-06-2026
yahoo.com
Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update
14-08-2026
yahoo.com
Is Vistagen Therapeutics, Inc. (VTGN) a Breakout Anxiety Drug Stock After New Phase 3 Extension Results?
19-05-2026
yahoo.com
Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder
30-06-2026
yahoo.com
Is Vistagen Therapeutics, Inc. (VTGN) Stock Facing New Challenges After PALISADE-4 Clinical Trial Results?
15-07-2026
yahoo.com
Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
06-08-2026
yahoo.com
Vistagen Achieves Minimum ICH Safety Exposure Recommendations Across Clinical Program for Fasedienol for the Acute Treatment of Social Anxiety Disorder
09-06-2026
yahoo.com
Vistagen Appoints Douglas J. Williamson to its Board of Directors
31-07-2026
yahoo.com
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
04-08-2026
yahoo.com
SRX Global Acquires Stake in Vistagen Therapeutics
04-08-2026
advfn.com
What is the current price of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?
The current price of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is $0.251.
VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) since the previous trading day is $0.0026.
VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) since the previous trading day is 1.0467%.
What is the most recent average sentiment score for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?
The most recent average sentiment score for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?
The most recent sentiment for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is .
SEC-8K** Filing Available For VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.